The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...

Here is a link to watch the earliest episodes of Donald Trump’s mid-aughts reality show, “The Apprentice,” now streaming on ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.